Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus
Section snippets
Materials and methods
Study participants. We studied patients who visited our hospital between April 2002 and July 2002. The inclusion criteria were the presence of type 2 diabetes mellitus, treated with/without an oral hypoglycemic agent and/or insulin for at least one year. We excluded patients with the above criteria but had a history of alcohol abuse, evidence of liver disease, or severe cardiac problems. We also included a control group consisting of 24 individuals referred to our department for admission who
Patients characteristics
A total of 106 diabetic patients and 7 patients with hyperlipidemia were enrolled in this study (Table 1). Peripheral blood MCP-1 levels were significantly (p < 0.05) higher in diabetic patients than in the normal control or in hyperlipidemic patients (Fig. 1). There was no significant difference in serum MCP-1 level based on the type of medications and there were no significant differences in body mass index (BMI), FPG, HbA1c, total cholesterol, triglyceride, hs-CRP between patients with
Discussion
Although a great deal has been reported on vessel wall stiffness and the prevalence of inflammatory markers in association with endothelial dysfunction, very little attention has been paid to the state of peripheral blood monocytes in diabetes associated with atherosclerosis [20]. In this study, we measured peripheral blood MCP-1 concentrations and CCR2 expression on silent monocytes isolated by counterflow centrifugal elutriation in diabetic patients with the aim of determining the relevance
Acknowledgments
This work was supported in part by a Grant-in-Aid for Scientific Research by the Ministry of Health, Labor, and Welfare of Japan, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a Grant from the University of Occupational and Environmental Health, Japan.
References (29)
- et al.
Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging
J. Diabetes Complicat.
(2003) New approaches for treatment in diabetes: aldose reductase inhibitors
Biomed. Pharmacother.
(1995)- et al.
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis
Atherosclerosis
(2004) - et al.
An enzymatic method for the measurement of glycated albumin in biological samples
Clin. Chim. Acta
(2002) - et al.
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis
Cell Immunol.
(1984) - et al.
Regulation of expression of the human monocyte chemoattractant protein-1 receptor (hCCR2) by cytokines
J. Biol. Chem.
(1997) - et al.
Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells
Biochem. Biophys. Res. Commun.
(2003) - et al.
The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein
J. Biol. Chem.
(2000) - et al.
Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages
Biochem. Biophys. Res. Commun.
(2000) - et al.
Glycated albumin and cross-linking of CD44 induce scavenger receptor expression and uptake of oxidized LDL in human monocytes
Biochem. Biophys. Res. Commun.
(2006)
Levels of expression of Fcγ receptor IIA (CD32) are decreased on peripheral blood monocytes in patients with severe atherosclerosis
Atherosclerosis
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
Circulation
Chronic vascular inflammation in patients with type 2 diabetes
Diabetes Care
Oxidative stress and diabetic vascular complications
Diabetes Care
Cited by (62)
LPS differentially affects expression of CD14 and CCR2 in monocyte subsets of Post-STEMI patients with hyperglycemia
2022, Diabetes Research and Clinical PracticeCitation Excerpt :Together, these monocyte alterations likely contribute to the sustained inflammation that leads to the development of CHF following STEMI [36]. Elevated blood glucose has been suggested to enhance CCR2 expression and inflammation by increasing monocyte CCL2 production in response to CCR2-CCL2 binding [47–49]. Although the current investigation was unable to confirm these findings, Mine et al. [47] excluded subjects with CAD, which could explain the dissimilar results that were observed within the present study.
Insulin resistance and impaired adipogenesis
2015, Trends in Endocrinology and Metabolism